Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.6.4 has been added to the study record history, and the previous v3.6.3 entry has been removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe record history now shows Revision: v3.6.3 as the latest version, replacing v3.6.2, signaling a new update to the study record history.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page's revision entry now shows Revision: v3.6.2, replacing the previous v3.6.0, signaling a deployment of a newer page version.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study history now shows enrollment is closed and a new revision tag (v3.6.0) was added, replacing the previous revision (v3.5.5) to reflect an updated version of the record.SummaryDifference0.2%

- Check56 days agoChange DetectedRevision: v3.5.5 replaces v3.5.4 in the page's history, indicating an update to the page's version metadata. This update does not modify the study data or visible content.SummaryDifference0.1%

- Check70 days agoChange DetectedNew entries for Contacts/Locations and Study Status were added to the study history. An older change entry dated 2025-12-02 was removed.SummaryDifference0.3%

Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.